Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
08/2007
08/23/2007WO2007093829A1 3-aminopyrazolines for treatment of neurodegenerative and psychiatric diseases
08/23/2007WO2007093595A1 Substituted prolinamides, their preparation and their use as pharmaceuticals
08/23/2007WO2007093542A1 Pyridine-2-carboxamide derivatives
08/23/2007WO2007093540A1 Benzoyl-piperidine derivatives as 5ht2/d3 modulators
08/23/2007WO2007093402A1 Pesticides containing a bicyclic bisamide structure
08/23/2007WO2007093366A1 Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
08/23/2007WO2007093364A1 Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
08/23/2007WO2007071396A3 Pyrazinoylguanidine compounds useful in the treatment of inflammatory or allergic conditions
08/23/2007WO2007061741A3 Modulators of the h3 receptor useful for the treatment of disorders related thereto
08/23/2007WO2007059257A3 N4-phenyl-quinaz0line-4 -amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
08/23/2007US20070197783 Compositions and methods of treating cell proliferation disorders
08/23/2007US20070197619 Ion Channel Modulators
08/23/2007US20070197603 Substituted indole ligands for the orl-1 receptor
08/23/2007US20070197596 5-HT 2A antagonists; psychoses, schizophrenia, depression, neurological disorders, memory disorders, Parkinson's disease, amyotrophic lateral sclerosis, Alzheimer's, Huntington's, eating disorders, sleep apnoea, premenstrual syndrome; obsessive-compulsive disorder (OCD);
08/23/2007US20070197590 Substituted dipiperidine ccr2 antagonists
08/23/2007US20070197587 Quinoline Derivatives as CRTH2 Antagonists
08/23/2007US20070197551 such as 3-amino-5,6-dimethyl-2-[3-(4-quinolin-2-ylpiperazin-1-yl)propylthio]-3H-thieno[2,3-d]pyrimidin-4-one, having serotonin receptor modulatory activity, used for treating irritable bowel syndrome
08/23/2007US20070197549 Tetrazole compounds and their use as metabotropic glutamate receptor antagonists
08/23/2007US20070197547 4-(1-piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 4-(1-piperazinyl)-1-methyl-3-nitro-2(1H)-quinolone
08/23/2007US20070197546 Quinoline-4-carboxamide as nk-2 and nk-3 receptor antagonists
08/23/2007US20070197545 Crystalline Polymorphs Of Methanesulfonic Acid Addition Salts Of Imatinib
08/23/2007US20070197542 hydroxy{(1S)-4-pyrimidin-2-yl-1-[({4-[5-(2,2,2-trifluoroethoxy)pyrimidin-2-yl]piperazin-1-yl}sulfonyl)methyl]butyl}formamide; collagenase 3 inhibitor; tissue remodelling such as embryonic development, bone formation and uterine remodelling during menstruation
08/23/2007US20070197536 Pyridazin-3(2)-one derivatives and their use as pde4 inhibitors
08/23/2007US20070197534 3-ethyl-6-[3-(4-morpholinyl)propoxy]-1,2,4-benzotriazine 1,4-dioxide; for treating cancer; radiosensitising in a subject tumor cells of solid tumors in hypoxic conditions
08/23/2007US20070197533 Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds
08/23/2007US20070197531 Benzoyl-piperidine derivatives as dual modulators of the 5-HT2A and D3 receptors
08/23/2007US20070197530 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: 1'-{[1-(4-Chlorophenyl)cyclo-pentyl]carbonyl}-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
08/23/2007US20070197513 calcium channel modulator; [[1-(4-{2-[1-(4-Chloro-phenyl)-2-(2-methoxy-phenyl)-1H-imidazol-4-yl]-ethyl}-(4-fluoro-phenyl)-methyl-amine; analgesic, antidiabetic agent; angina, hypertension, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders
08/23/2007US20070197509 Compositions and methods for modulating gated ion channels
08/23/2007US20070197500 3-(2,3-Dihydro-1'H-spiro[indene-1,4'-piperidin]-1'-yl)-N,N-dimethyl-2-(pyridin-2-ylmethyl)propanamide; opioid receptor-like 1 antagonist; reduced inhibitory activity at HERG potassium channel; analgesic; side effect reduction; neurpathic and other pain
08/23/2007US20070197499 Pharmaceutical compounds
08/23/2007US20070197391 Herbicidal pyrimidines
08/23/2007US20070194698 Charge transport compositions and electronic devices made with such compositions
08/23/2007DE102006005861A1 Substituierte Chinolone III Substituted Quinolones III
08/23/2007CA2652648A1 Dihydrodiazepines useful as inhibitors of protein kinases
08/23/2007CA2642668A1 Indole-3-carboxylic acid amide and ester compounds bearing phenyl groups having sphingosine-1-phosphate (sip) receptor antagonist biological activity
08/23/2007CA2642275A1 Stable dosage formulations of imidazolylalkyl-pyridines
08/23/2007CA2641912A1 Substituted prolinamides, their preparation and their use as pharmaceuticals
08/23/2007CA2640807A1 Benzoyl-piperidine derivatives as 5ht2/d3 modulators
08/23/2007CA2640582A1 Pyridine-2-, pyrimidine-2-carboxamide derivatives
08/23/2007CA2640307A1 Pesticides containing a bicyclic bisamide structure
08/23/2007CA2638787A1 Cyclic amine compound and use thereof for the prophylaxis or treatment of hypertension
08/23/2007CA2636873A1 Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
08/23/2007CA2636617A1 Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
08/22/2007EP1820801A1 Organic compound, charge-transporting material, and organic electroluminescent element
08/22/2007EP1820799A1 2,3,4,5-tetrahydro-1h-1,5-benzodiazepine derivative and medicinal composition
08/22/2007EP1820798A1 7-membered ring compound, process for producing the same, and medicinal use thereof
08/22/2007EP1820797A1 Substituted pyridone derivative
08/22/2007EP1820503A2 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
08/22/2007EP1819696A1 Polymorphic forms of 6-2-(methylcarbamoyl)phenysulfanyl|-3-e-2-(pyridin-2-yl)ethenyl indazole
08/22/2007EP1819695A1 Anthranilamide derivatives as insecticides
08/22/2007EP1819694A2 SALTS OF N-[2-({3R)-1-[trans-4-HYDROXY-4-(6-METHOXYPYRIDIN-3-YL)-CYCLOHEXYL]PYRROLIDINE-3-YL}AMINO)-2-OXOETHYL]-3-(TRIFLUOROMETHYL)BENZAMIDE
08/22/2007EP1819693A1 Antithrombotic diamides
08/22/2007EP1819691A2 Biaryloxymethylarene carboxylic acids
08/22/2007EP1819676A2 5-phenyl-5,6,7,8-hydroquinoline tachykinin receptor antagonists
08/22/2007EP1819672A1 Indole-2-carboxylic acid amides
08/22/2007EP1819667A1 Sulfonamide compounds as cysteine protease inhibitors
08/22/2007EP1819341A2 Il-12 modulatory compounds
08/22/2007EP1819337A2 Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
08/22/2007EP1720870B1 Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments
08/22/2007EP1578755B1 Phosphonooxy quinazoline derivatives and their pharmaceutical use
08/22/2007EP1567502B1 Substituted dihydrophenanthridinesul fonamides
08/22/2007EP1554246B1 Dihydropyridinone derivatives as hne inhibitors
08/22/2007EP1448523B1 Heterocyclic compounds and methods of use
08/22/2007EP1399433B1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
08/22/2007EP1359908B1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents
08/22/2007EP1300399B1 Phenylpyridazine derivatives and drugs containing the same
08/22/2007EP1150980B1 16-halogen-epothilone derivatives, method for producing them and their pharmaceutical use
08/22/2007EP1150970B1 (1-phenacy-3-phenyl-3-piperidylethyl)piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same
08/22/2007EP1136470B1 Process for the preparation of a piperazine derivative
08/22/2007CN1332959C Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
08/22/2007CN1332952C 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) im
08/22/2007CN1332942C Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists
08/22/2007CN1332939C Novel compounds inhibiting factor Xa activity
08/22/2007CN101023074A Inhibitors of the interaction between MDM2 and P53
08/22/2007CN101023073A Heteroaroyl-substituted serine amides utilized as herbicides
08/22/2007CN101023072A Piperidinyl targeting compounds that selectively bind integrins
08/22/2007CN101023071A New heterocyclic amides
08/22/2007CN101023070A Method for the production of dihydropteridinones
08/22/2007CN101023064A Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
08/22/2007CN101023063A Azine-carboxamides as anti-cancer agent
08/22/2007CN101023061A Method for chiral inversion of (S)-(+)- and (R)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and optically enriched mixtures thereof
08/22/2007CN101022728A Imidazole compounds
08/22/2007CN101020659A 9-aminoalkylamido-1-azabenznthrone derivative and its synthesis and application
08/22/2007CN101020654A Antitumor compound and its prepn process
08/21/2007US7259266 Benzopyran compounds useful for treating inflammatory conditions
08/21/2007US7259182 Deep vein thrombosis, noninsulin dependent diabetes, atherosclerosis, and pulmonary fibrosis treatment; cardiovascular and brain disorders
08/21/2007US7259179 Kinase inhibitors
08/21/2007US7259174 1-(Hetero)aryl- and 3-substituted with a group containing an arylaldehyde oxime, e.g., 4-[5-(2-oxo-3-pyridin-4-yl-imidazolidin-1-yl)-pentyloxy]-benzaldehyde O-methyl-oxime; treating enteroviral infections
08/21/2007US7259172 Inhibitors of β-lactamase
08/21/2007US7259165 especially 3-sulfonylpyrazolo[4.3b]pyridines and 3-sulfonylpyrrolo[3.2b] and [2.3b]pyridines; treatment of a central nervous system disorder related to or affected by the 5-HT6 receptor, such as attention deficit disorder; obsessive compulsive disorder; and withdrawal from drug, alcohol or nicotine
08/21/2007US7259163 Viricides against herpes virus
08/21/2007US7259160 Hexahydrodiazepinones as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
08/21/2007US7259158 Naphthaline derivatives as H3 inverse agonists
08/21/2007US7259157 N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists
08/21/2007US7259155 Phosphonic diester derivatives
08/21/2007CA2315827C Substituted pyridine and pyridazine compounds and their pharmaceutical use
08/21/2007CA2304965C ((cyclo)alkyl substituted)-gamma-aminobutyric acid derivatives (=gaba analogues), their preparation and their use in the treatment of neurological disorders
08/16/2007WO2007092531A2 Compounds and compositions as protein kinase inhibitors
08/16/2007WO2007092435A2 11-beta hsd1 inhibitors
1 ... 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 ... 1080